Archive
Every story, newest first.
Monday, November 9, 2026
Infrastructure
South African payments company Yoco, backed by TPG, has secured a 100 million dollar credit facility from Victory Park Capital, its first direct debt deal, to fund cash advances to its 200,000 merchants.
Infrastructure
Panamint Capital closed 769 million dollars of financing for a 491 megawatt Texas solar project, Cube Infrastructure reached a 587 million euro first close on its fourth fund, and RadianX raised 9 million dollars for perovskite module production.
Infrastructure
EU net greenhouse gas emissions fell 1.6 percent in 2025 to 39 percent below 1990 levels, and projections with all planned measures reach a 54 percent cut by 2030 against a binding 55 percent target.
Infrastructure
Aliko Dangote said on November 8 that the Dangote Petroleum Refinery public offer missed its target of 10 million investors, even though orders reached about 6.4 trillion naira against a 2.15 trillion naira offer.
Infrastructure
CNH Industrial has agreed to sell 70 percent of its construction equipment business to Kobelco Construction Machinery in a joint venture valuing the business at an enterprise value of 1 billion dollars, with CNH receiving 700 million dollars in cash and retaining 30 percent.
Infrastructure
Alcazar Energy Partners has reached financial close on two Egyptian wind farms costing a combined 626 million dollars, securing 436 million dollars of debt in equal shares from the EBRD, the European Investment Bank and DEG.
Life Sciences
Edesa licensed its ARDS antibody to Kyorin in Japan for 12 million dollars upfront, five liver societies published one global definition of acute-on-chronic liver failure, and an AHA abstract found volunteer alert apps did not raise bystander CPR rates.
Life Sciences
ImmunityBio said ANKTIVA plus BCG met the primary efficacy endpoint of the 370 patient QUILT-2.005 registrational trial in BCG-naive bladder cancer, and a supplemental FDA filing remains on track for year end 2026.
Life Sciences
The RACE-CARS randomised trial across 60 North Carolina counties found survival with good brain function of 9.0 percent with intensive community and EMS training against 9.4 percent with usual care.
Life Sciences
Abeona reported third quarter ZEVASKYN revenue of 13.5 million dollars, up 18 percent sequentially, and acquired the Phase 3-ready eosinophilic esophagitis drug APT-1011 alongside a 30 million dollar PIPE financing.